Tat-SmacN7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis

15Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

A major concern in cancer therapy is resistance of tumors such as human non-small cell lung cancer and esophageal cancer to radiotherapy. Intrinsic radioresistance of these cancer cells limits therapeutic efficiency. Here, we determined in two cancer cell lines the potential radiosensitizing activity of Tat-SmacN7, a small molecule compound, which mimics the activity of Smac, a mitochondrial protein released during apoptosis. We found that Tat-SmacN7 can enter the cells and promote RNA expression and the activity of caspase-3, -8 and -9 and sensitized the cancer cells to radiation with a sensitization enhancement ratio (SER) of 1.5-1.6. Tat-SmacN7 radiosensitization was mediated by both extrinsic and intrinsic apoptosis pathways through activation of caspases. Consistently, blockage of caspase activation, through treatment with a caspase inhibitor, z-VAD-fmk, inhibited apoptosis and abrogated Tat-SmacN7 radiosensitization. Our study demonstrates that Tat-SmacN7 also has radiosensitization effects in vivo, so it could be further developed as a novel class of radiosensitizers for the treatment of radioresistant human non-small cell lung cancer and esophageal cancer.

Cite

CITATION STYLE

APA

Chen, F., Xu, C., Du, L., Wang, Y., Cao, J., Fu, Y., … Fan, F. (2013). Tat-SmacN7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis. International Journal of Oncology, 42(3), 985–992. https://doi.org/10.3892/ijo.2013.1785

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free